Crossmark

Prognostic impact of cytogenetic alterations in newly diagnosed acute myeloid leukemia treated with risk-adapted protocols

Crossref DOI link: https://doi.org/10.1016/j.medcle.2025.107106

Published Print: 2025-10

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Ruiz-Xivillé, Neus

Morgades, Mireia

Blanco, Laura

Costa, Dolors

Espinet, Blanca

Talavera, Elisabet

Triviño, Emma

Ortega, Margarita

Villamon, Eva

Zamora, Lurdes

Navarro, José Tomás

Arnan, Montserrat

Vives, Susana

Esteve, Jordi

Sierra, Jorge

Ribera, Josep-Maria

Granada, Isabel
License Information

Text and Data Mining valid from 2025-10-01

Text and Data Mining valid from 2025-10-01

stm-asf valid from 2025-10-01

stm-asf valid from 2025-10-01

stm-asf valid from 2025-10-01

stm-asf valid from 2025-10-01

stm-asf valid from 2025-10-01
More Information

This article is maintained by: Elsevier

Article Title: Prognostic impact of cytogenetic alterations in newly diagnosed acute myeloid leukemia treated with risk-adapted protocols

Journal Title: Medicina Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medcle.2025.107106

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.medcli.2025.107106

Content Type: article

Copyright: © 2025 Published by Elsevier España, S.L.U.